CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth.

In contrast, the group of metastatic primary hLT (pT × N2) showed a highly significant difference (mean CD9P-1 index±s.e.m.: 2.179±0.436; P =0.0003; 95% CI=−1.938 to −0.6739) compared with the group of primary hLT (pT × N0) ( Figure 2B ).

also in 132,142 other papers